Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer- related death in Western countries and among the malignancies with the worst prognosis. Osteonectin and osteopontin, two proteins of the extracellular matrix, have been found to be up-regulated in PDAC. In the present stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhivkova-Galunska, Maria (VerfasserIn) , Adwan, Hassan (VerfasserIn) , Eyol, Ergül (VerfasserIn) , Kleeff, Jörg H. (VerfasserIn) , Kolb, Armin (VerfasserIn) , Bergmann, Frank (VerfasserIn) , Berger, Martin R. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2010
In: Cancer biology & therapy
Year: 2010, Jahrgang: 10, Heft: 1, Pages: 54-64
ISSN:1555-8576
DOI:10.4161/cbt.10.1.12161
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.4161/cbt.10.1.12161
Volltext
Verfasserangaben:Maria Zhivkova-Galunska, Hassan Adwan, Ergül Eyol, Jörg Kleeff, Armin Kolb, Frank Bergmann, Martin R. Berger
Beschreibung
Zusammenfassung:Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer- related death in Western countries and among the malignancies with the worst prognosis. Osteonectin and osteopontin, two proteins of the extracellular matrix, have been found to be up-regulated in PDAC. In the present study the expression of osteopontin mRNA as determined in a panel of 14 hu­man pancreatic cancer cell lines was significantly related to the growth these cell lines in the liver of nude rats (p=0.001) whereas osteonectin showed a trend of being negatively related to pancreatic cancer cell growth in vivo (p=0.10). In an in vitro co-culture model of human Suit2-007 and rat AsML PDAC cells with rat hepatocytes, a clearly increased expression of OPN mRNA was found in the tumor cells. In addition both, down-regulation of osteopontin with specific antisense oligonucleotides and treatment with exogenous rh-osteonectin were associated with reduced cell proliferation. In accordance with the latter finding down-regula­tion of osteonectin was coupled with increased proliferation. This evidence supports a protu­morigenic role of osteopontin and points to an anti-tumorigenic role of osteonectin in PDAC.
Beschreibung:Gesehen am 12.03.2024
Beschreibung:Online Resource
ISSN:1555-8576
DOI:10.4161/cbt.10.1.12161